İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey

Dergi Turk J Gastroenterol ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN2148-5607
YÖKSİS OpenAlex Açık erişim · diamond TR Index
Yıl2022
Atıf4OpenAlex
Yüzdelik%56,5
FWCI0,381,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıTurk J Gastroenterol
  • Katalog eşleşmesi (ISSN)Turkish Journal of Gastroenterology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND: The number and proportion of elderly patients living with chronic hepatitis C are expected to increase in the coming years. We aimed to compare the real-world efficacy and safety of direct-acting antiviral treatment in elderly and younger Turkish adults infected with chronic hepatitis C. METHODS: In this multicenter prospective study, 2629 eligible chronic hepatitis C patients treated with direct-acting antivirals between April 2017 and December 2019 from 37 Turkish referral centers were divided into 2 age groups: elderly (≥65 years) and younger adults (<65 years) and their safety was compared between 2 groups in evaluable population. Then, by matching the 2 age groups for demographics and pretreatment risk factors for a non-sustained virological response, a total of 1516 patients (758 in each group) and 1244 patients (622 in each group) from the modified evaluable population and per-protocol population were included in the efficacy analysis and the efficacy was compared between age groups. RESULTS: The sustained virological response in the chronic hepatitis C patients was not affected by the age and the presence of cirrhosis both in the modified evaluable population and per-protocol population (P = .879, P = .508 for modified evaluable population and P = .058, P = .788 for per-protocol population, respectively). The results of the per-protocol analysis revealed that male gender, patients who had a prior history of hepatocellular carcinoma, patients infected with non-genotype 1 hepatitis C virus, and patients treated with sofosbuvir+ribavirin had a significantly lower sustained virological response 12 rates (P < .001, P = .047, P = .013, and P = .025, respectively). CONCLUSION: Direct-acting antivirals can be safely used to treat Turkish elderly chronic hepatitis C patients with similar favorable efficacy and safety as that in younger adults.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

4atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

44
  1. YUSUF ÖNLEN 1
  2. TAYİBE BAL BOLU ABANT İZZET BAYSAL ÜNİVERSİTESİ 2
  3. MEHMET ÇABALAK 3
  4. NEFİSE ÖZTOPRAK ÇUVALCI 4
  5. NAGEHAN DİDEM SARI 5
  6. BEHİCE KURTARAN 6
  7. EBUBEKİR ŞENATEŞ 7
  8. ALPER ŞENER 8
  9. ESRA ZERDALİ 9
  10. HASAN KARSEN 10
  11. AYŞE BATIREL 11
  12. RIDVAN KARAALİ 12
  13. HATİCE RAHMET GÜNER 13
  14. TANSU YAMAZHAN 14
  15. ŞÜKRAN KÖSE 15
  16. NURETTİN ERBEN ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ 16
  17. NEVİN İNCE 17
  18. İFTAHAR KÖKSAL ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ 18
  19. FİGEN SARIGÜL YILDIRIM 19
  20. GÜLŞEN YÖRÜK 20
  21. SÜHEYLA KÖMÜR 21
  22. SİBEL YILDIZ KAYA 22
  23. ŞABAN ESEN 23
  24. ÖZGÜR GÜNAL SAMSUN ÜNİVERSİTESİ 24
  25. İLKNUR ESEN YILDIZ 25
  26. DİLARA İNAN 26
  27. HÜSEYİN ŞENER BARUT 27
  28. MUSTAFA NAMIDURU 28
  29. SELMA TOSUN 29
  30. KAMURAN TÜRKER 30
  31. KENAN HIZEL 31
  32. NURCAN BAYKAM 32
  33. FAZİLET DUYGU 33
  34. ESRAGÜL AKINCI 34
  35. GÜRAY CAN 35
  36. ÜLKÜ ÜSER 36
  37. HANEFİ CEM GÜL 37
  38. AYHAN AKBULUT 38
  39. GÜVEN ÇELEBİ 39
  40. MAHMUT SÜNNETÇİOĞLU 40
  41. OĞUZ KARABAY 41
  42. HAYAT KUMBASAR KARAOSMANOĞLU 42
  43. FATMA SIRMATEL 43
  44. ÖMER FEHMİ TABAK İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA 44